1.1 Industry Outlook
1.1.1 Market Definition
1.1.2 Supply Chain Analysis
1.1.3 Ecosystem/Ongoing Programs
1.1.3.1 Governments Initiatives
1.1.3.2 Consortiums and Associations
1.1.4 Patent Analysis
1.1.4.1 Patent Analysis (by Status)
1.1.4.2 Patent Analysis (by Inventor Type)
1.1.4.3 Patents Analysis (by Patent Office)
1.1.5 Supply Demand Analysis
1.1.6 Government Body Regulations in Asia-Pacific Region
1.2 Business Dynamics
1.2.1 Business Drivers
1.2.1.1 Growing Awareness Regarding Health Benefits of Omega-3
1.2.1.2 Increasing Cases of Chronic Diseases
1.2.1.3 Support from Government Organization and Institutions
1.2.2 Business Challenges
1.2.2.1 Volatility in the Prices of PUFA Sources
1.2.2.2 Harmful Effects of High Ratio Consumption
1.2.3 Business Strategies
1.2.3.1 Product Development
1.2.3.2 Market Development
1.2.4 Corporate Strategies
1.2.4.1 Mergers and Acquisitions
1.2.4.2 Partnerships, Collaborations, and Joint Ventures
1.2.4.3 Others
1.2.5 Business Opportunities
1.2.5.1 Increasing Aged Population
1.2.5.2 Search for Innovative Sources of PUFA
1.2.5.3 Growing Market for Supplements in Asia-Pacific Region
1.3 A Shift in the Trend from Animal-Based to Plant-Based PUFAs Products
1.4 Impact of COVID-19 on the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
2.1 Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Product Type)
2.1.1 Omega-3
2.1.1.1 Docosahexaenoic Fatty Acid (DHA)
2.1.1.2 Others (Eicosapentanoic Fatty Acid (EPA) and Alpha-Linolenic Fatty Acid (ALA))
2.1.2 Omega-6
2.1.2.1 Arachidonic Fatty Acid (ARA)
.1.2.2 Others Linoleic Fatty Acid (LA) and Gamma-Linolenic Fatty Acid (GLA)
2.2 Demand Analysis of the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Product Type)
2.3 Food Source
2.3.1 Plant Sources
2.3.1.1 Microalgae
2.3.1.2 Others (Vegetables, Seeds)
2.3.2 Animal Sources
2.3.2.1 Fish
2.3.2.2 Shrimp
2.3.2.3 Others
3.1 Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (By Application)
3.1.1 Pharmaceutical
3.1.2 Dietary Supplements
3.1.3 Food and Beverages
3.1.4 Animal Feed
3.1.5 Others (Cosmetics, etc.)
3.2 Demand Analysis of the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Application)
4. By Country
4.1 China
4.1.1 Market
4.1.1.1 Buyer Attributes
4.1.1.2 Key Companies Operating in China
4.1.1.3 Business Challenges
4.1.1.4 Business Drivers
4.1.2 Application
4.1.2.1 China Polyunsaturated Fatty Acids (PUFAs) Market (by Application)
4.1.3 Product
4.1.3.1 China Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source)
4.2 India
4.2.1 Market
4.2.1.1 Buyer Attributes
4.2.1.2 Key Companies Operating in India
4.2.1.3 Business Challenges
4.2.1.4 Business Drivers
4.2.2 Application
4.2.2.1 India Polyunsaturated Fatty Acids (PUFAs) Market (by Application)
4.2.3 Product
4.2.3.1 India Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source)
4.3 Japan
4.3.1 Market
4.3.1.1 Buyer Attributes
4.3.1.2 Key Companies Operating in Japan
4.3.1.3 Business Challenges
4.3.1.4 Business Drivers
4.3.2 Application
4.3.2.1 Japan Polyunsaturated Fatty Acids (PUFAs) Market (by Application)
4.3.3 Product
4.3.3.1 Japan Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source)
4.4 South Korea
4.4.1 Market
4.4.1.1 Buyer Attributes
4.4.1.2 Key Companies Operating in South Korea
4.4.1.3 Business Challenges
4.4.1.4 Business Drivers
4.4.2 Application
4.4.2.1 South Korea Polyunsaturated Fatty Acids (PUFAs) Market (by Application)
4.4.3 Product
4.4.3.1 South Korea Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source)
4.5 Singapore
4.5.1 Market
4.5.1.1 Buyer Attributes
4.5.1.2 Key Companies Operating in Singapore
4.5.1.3 Business Challenges
4.5.1.4 Business Drivers
4.5.2 Application
4.5.2.1 Singapore Polyunsaturated Fatty Acids (PUFAs) Market (by Application)
4.5.3 Product
4.5.3.1 Singapore Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source)
4.6 Malaysia
4.6.1 Market
4.6.1.1 Buyer Attributes
4.6.1.2 Key Companies Operating in Malaysia
4.6.1.3 Business Challenges
4.6.1.4 Business Drivers
4.6.2 Application
4.6.2.1 Malaysia Polyunsaturated Fatty Acids (PUFAs) Market (by Application)
4.6.3 Product
4.6.3.1 Malaysia Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source)
4.7 Thailand
4.7.1 Market
4.7.1.1 Buyer Attributes
4.7.1.2 Key Companies Operating in Thailand
4.7.1.3 Business Challenges
4.7.1.4 Business Drivers
4.7.2 Application
4.7.2.1 Thailand Polyunsaturated Fatty Acids (PUFAs) Market (by Application)
4.7.3 Product
4.7.3.1 Thailand Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source)
4.8 Australia and New Zealand
4.8.1 Market
4.8.1.1 Buyer Attributes
4.8.1.2 Key Companies Operating in Australia and New Zealand
4.8.1.3 Business Challenges
4.8.1.4 Business Drivers
4.8.2 Application
4.8.2.1 Australia and New Zealand Polyunsaturated Fatty Acids (PUFAs) Market (by Application)
4.8.3 Product
4.8.3.1 Australia and New Zealand Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source)
4.9 Rest-of-Asia-Pacific
4.9.1 Market
4.9.1.1 Buyer Attributes
4.9.1.2 Key Companies Operating in Rest-of-Asia-Pacific
4.9.1.3 Business Challenges
4.9.1.4 Business Drivers
4.9.2 Application
4.9.2.1 Rest-of-Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Application)
4.9.3 Product
4.9.3.1 Rest-of-Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source)
5.1 Competitive Benchmarking
5.2 Market Share Analysis
5.3 Manufacturing Facility and Presence in Asia-Pacific
5.4 Company Profiles
5.4.1 Aker BioMarine ASA
5.4.1.1 Company Overview
5.4.1.2 Role of Aker BioMarine ASA in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.1.3 Product Portfolio
5.4.1.4 Business Strategies
5.4.1.4.1 Product Launch
5.4.1.5 Corporate Strategies
5.4.1.5.1 Mergers and Acquisitions
5.4.1.5.2 Partnerships, Collaborations, Joint Ventures, and Alliances
5.4.1.6 Strength and Weakness of Aker BioMarine ASA
5.4.2 BASF SE
5.4.2.1 Company Overview
5.4.2.2 Role of BASF SE in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.2.3 Product Portfolio
5.4.2.4 Corporate Strategies
5.4.2.4.1 Partnerships, Collaborations, Joint Ventures, and Alliances
5.4.2.5 Strength and Weakness of BASF SE
5.4.3 CABIO Biotech (Wuhan) Co., Ltd.
5.4.3.1 Company Overview
5.4.3.2 Role of CABIO Biotech (Wuhan) Co., Ltd in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.3.3 Product Portfolio
5.4.3.4 Business Strategies
5.4.3.4.1 Expansion
5.4.3.4.2 Product Launch
5.4.3.5 Strength and Weakness of CABIO Biotech (Wuhan) Co., Ltd
5.4.4 Cargill, Incorporated.
5.4.4.1 Company Overview
5.4.4.2 Role of Cargill, Incorporated. in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.4.3 Product Portfolio
5.4.4.4 Business Strategies
5.4.4.4.1 Market Development
5.4.4.4.2 Product Developments
5.4.4.5 Strength and Weakness of Cargill, Incorporated.
5.4.5 Cellana, Inc.
5.4.5.1 Company Overview
5.4.5.2 Role of Cellana, Inc. in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.5.3 Product Portfolio
5.4.5.4 Corporate Strategies
5.4.5.4.1 Partnerships, Joint Ventures, Collaborations, and Alliances
5.4.5.5 Strength and Weakness of Cellana, Inc.
5.4.6 Pharmalab India Private Limited
5.4.6.1 Company Overview
5.4.6.2 Role of Clover Corporation in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.6.3 Product Portfolio
5.4.6.4 Business Strategies
5.4.6.4.1 Product Launch
5.4.6.5 Strength and Weakness of Clover Corporation
5.4.7 Croda International PLC
5.4.7.1 Company Overview
5.4.7.2 Role of Croda International PLC in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.7.3 Product Portfolio
5.4.7.4 Strength and Weakness of Croda International PLC
5.4.8 DSM
5.4.8.1 Company Overview
5.4.8.2 Role of DSM in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.8.3 Product Portfolio
5.4.8.4 Business Strategies
5.4.8.4.1 Product Launch
5.4.8.5 Corporate Strategies
5.4.8.5.1 Partnerships, Joint Ventures, Collaborations, and Alliances
5.4.8.5.2 Mergers and Acquisitions
5.4.8.6 Strength and Weakness of DSM
5.4.9 KinOmega Biopharm Inc.
5.4.9.1 Company Overview
5.4.9.2 Role of Guangdong Runke Bioengineering Co. Ltd. in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.9.3 Product Portfolio
5.4.9.4 Strength and Weakness of Guangdong Runke Bioengineering Co. Ltd.
5.4.10 Huatai Biopharm Inc
5.4.10.1 Company Overview
5.4.10.2 Role of Huatai in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.10.3 Product Portfolio
5.4.10.4 Strength and Weakness of Huatai
著作権 ©2022 無断複写・転載を禁じます
